Karolinska report

New drugs and survival: does the Karolinska report make sense?

Number 14

Senza categoria 1 September 2006 0

Is it possible to demonstrate that access to new drugs impacts on a country’s survival rates? Last September, the Karolinska report claimed to have done just that. Here, Michel Coleman argues that its conclusions were [more]

A European report card

Number 9

Editorial 1 November 2005 0

Disparities in the speed at which patients in different European countries get access to the latest cancer drugs were highlighted last month in a report published by Stockholm’s Karolinska Institute. The Roche-sponsored study, launched at [more]